Cialis Owner Eli Lilly Climbs High On Profit

Date: 17th April 2007

With, the shares of Eli Lilly, the owner of the erectile dysfunction drug Cialis climbing 2.7 percent on heavy volume and posting a 52-week closing at the price of $58.40, the company has revealed its expectations of a full-year profit amounting to $3.30 to $3.40 a share in comparison to an earlier forecast of $3.25 to $3.35 a share.

According to Les Funtleyder, a drug analyst with Miller Tabak & Co., the profit gained by Eli Lilly has beaten the expectations of the Wall Street Journal regarding the earnings of Eli Lilly.

As a huge amount of profit has arrived in the way of Eli Lilly, the officials of the company have started to spread the message to investors stating that it is on its way to launch 12 new drugs in this decade. The Eli Lilly board has made clear its decision to pay an amount of 42.5 cents a share to the shareholders which was similar to the amount paid in the first quarter.   

Source: http://www.indystar.com